Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis
Author(s) -
Sarah Cuddy,
Paco E. Bravo,
Rodney H. Falk,
Samir El-Sady,
Marie Foley Kijewski,
MiAe Park,
Frederick L. Ruberg,
Vaishali Sanchorawala,
Heather Landau,
Andrew J. Yee,
Giada Bianchi,
Marcelo F. Di Carli,
Su-Chun Cheng,
Michael JeroschHerold,
Raymond Y. Kwong,
Ronglih Liao,
Sharmila Dorbala
Publication year - 2020
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2020.02.025
Subject(s) - cardiac amyloidosis , medicine , amyloidosis , interquartile range , al amyloidosis , amyloid (mycology) , positron emission tomography , magnetic resonance imaging , cardiac magnetic resonance imaging , cardiology , pathology , nuclear medicine , radiology , immunoglobulin light chain , immunology , antibody
The purpose of this study was to determine phenotypes characterizing cardiac involvement in AL amyloidosis by using direct (fluorine-18-labeled florbetapir {[ 18 F]florbetapir} positron emission tomography [PET]/computed tomography) and indirect (echocardiography and cardiac magnetic resonance [CMR]) imaging biomarkers of AL amyloidosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom